EA202191713A1 - SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, THEIR COMPOSITIONS AND THEIR TREATMENT METHODS - Google Patents

SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, THEIR COMPOSITIONS AND THEIR TREATMENT METHODS

Info

Publication number
EA202191713A1
EA202191713A1 EA202191713A EA202191713A EA202191713A1 EA 202191713 A1 EA202191713 A1 EA 202191713A1 EA 202191713 A EA202191713 A EA 202191713A EA 202191713 A EA202191713 A EA 202191713A EA 202191713 A1 EA202191713 A1 EA 202191713A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
aminophenyl
piperidine
amino
substituted
Prior art date
Application number
EA202191713A
Other languages
Russian (ru)
Inventor
Массимо Аммиранте
Соголе Бахманиар
Мэттью Д. Корреа
Вирджиния Грэнт
Джошуа Хансен
Эван Дж. Хорн
Тимоти С. Керхер
Кристофер Мэйн
Марк А. Нэйджи
Рама Кришна Нарла
Сурендра Наяк
Стефен Норрис
Патрик Папа
Вероник Плантевин-Кренитски
Джон Дж. Сапьенса
Брэндон У. Уайтфилд
Шуйчань Сюй
Original Assignee
Селджин Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Селджин Корпорейшн filed Critical Селджин Корпорейшн
Priority claimed from PCT/US2019/067090 external-priority patent/WO2020132016A1/en
Publication of EA202191713A1 publication Critical patent/EA202191713A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В настоящем документе предложены соединения пиперидиндиона, имеющие следующую структуру:где RN, R1, R2, R3, R4, X, L, V, m и n имеют значения, указанные в данном описании, композиции, содержащие эффективное количество соединения пиперидиндиона, и способы лечения или профилактики заболевания, опосредованного андрогеновым рецептором.Provided herein are piperidinedione compounds having the following structure: wherein RN, R1, R2, R3, R4, X, L, V, m, and n are as defined herein, compositions containing an effective amount of a piperidinedione compound, and methods of treatment or prevention of an androgen receptor mediated disease.

EA202191713A 2019-07-29 2019-12-18 SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, THEIR COMPOSITIONS AND THEIR TREATMENT METHODS EA202191713A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962879927P 2019-07-29 2019-07-29
PCT/US2019/067090 WO2020132016A1 (en) 2018-12-19 2019-12-18 Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith

Publications (1)

Publication Number Publication Date
EA202191713A1 true EA202191713A1 (en) 2022-03-04

Family

ID=81077499

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191713A EA202191713A1 (en) 2019-07-29 2019-12-18 SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, THEIR COMPOSITIONS AND THEIR TREATMENT METHODS

Country Status (1)

Country Link
EA (1) EA202191713A1 (en)

Similar Documents

Publication Publication Date Title
MX2021007473A (en) Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith.
MX2021007475A (en) Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith.
EA202092248A1 (en) SUBSTITUTED COMPOUNDS OF 4-AMINOISOINDOLINE-1,3-DIONE, THEIR COMPOSITIONS AND METHODS OF THEM TREATMENT
EA200601785A1 (en) CONNECTIONS AND METHODS OF TREATMENT OF DYSLIPIDEMIA
EA201990565A1 (en) CRYSTALLINE 19-NOR C3,3-DISPLACED C21-N-PYRAZOLYL STEROID
PH12021551167A1 (en) New heterocyclic compounds
EA202091508A1 (en) 6-AZAINDOL CONNECTIONS
EA202192019A1 (en) DERIVATIVES OF 3- (1-OXO-5- (PIPERIDIN-4-YL) ISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND ROUTES OF THEIR APPLICATION
MX2021014350A (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith.
EA202091484A1 (en) 4-AZAINDOL CONNECTIONS
EA201890086A1 (en) 1,4-substituted derivatives of piperidine
DE602006017694D1 (en) C-LINKED CYCLIC ANTAGONISTS OF THE P2Y1 RECEPTOR SUITABLE FOR THE TREATMENT OF THROMBOTIC SUFFERING
NO20090202L (en) Prolylhydroksylaseinhibitorer
AR036365A1 (en) 1,8-NAFTIRIDIN-4 (1H) -THE ALQUIN-ARIL SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201101398A1 (en) SUBSTITUTED PIPERIDINE AS AN ANTAGONIST CCR3
EA200801025A1 (en) COMPOSITION AND SYNTHESIS OF NEW REAGENTS FOR THE INHIBITION OF HIV REPLICATION
DE602005027230D1 (en) CGRP RECEPTOR ANTAGONIST
EA202191991A1 (en) NEW DERIVATIVES OF A HETEROTRICYCLIC COMPOUND AND THEIR APPLICATIONS
NO20064344L (en) Caspase Inhibitors and Uses thereof
EA202091477A1 (en) SUBSTITUTED INDOLESTER COMPOUNDS
EA202190464A1 (en) SUBSTITUTED BENZIMIDAZOLES AS PAD4 INHIBITORS
EA202190272A1 (en) ADDITIONALLY SUBSTITUTED TRIAZOLOQUINOXALINE DERIVATIVES
EA202190285A1 (en) AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS
EA202190271A1 (en) SUBSTITUTED TRIAZOLOQUINOXALINE DERIVATIVES
EA200600688A1 (en) ARYLINDENPYRIDINES AND ARYLINDENPYRIMIDINES AND THEIR APPLICATION AS ANTAGONISTS OF A2A Adenosine Receptor